Redmile Group, LLC - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$14,635,697
+9.4%
8,509,126
+24.0%
0.70%
+35.7%
Q2 2023$13,377,441
-30.5%
6,860,226
-1.0%
0.51%
-38.6%
Q1 2023$19,256,854
-19.5%
6,926,926
-0.1%
0.84%
-14.5%
Q4 2022$23,913,537
+33.8%
6,931,460
-0.3%
0.98%
+41.1%
Q3 2022$17,869,000
+6.2%
6,952,7600.0%0.69%
+7.9%
Q2 2022$16,826,000
-40.6%
6,952,760
+1.2%
0.64%
-27.4%
Q1 2022$28,312,000
-35.8%
6,871,738
+100.4%
0.88%
-11.9%
Q4 2021$44,099,000
+44.7%
3,429,171
+21.6%
1.00%
+88.9%
Q3 2021$30,468,000
+49.9%
2,821,085
+26.7%
0.53%
+76.4%
Q2 2021$20,325,000
-12.0%
2,226,206
-9.1%
0.30%
-7.4%
Q1 2021$23,086,000
+91.5%
2,448,158
-20.0%
0.32%
+122.6%
Q4 2020$12,056,000
+48.7%
3,059,7940.0%0.15%
-2.0%
Q3 2020$8,108,000
-60.2%
3,059,794
-0.2%
0.15%
-60.4%
Q2 2020$20,352,000
+14.0%
3,064,994
-0.1%
0.38%
-25.0%
Q1 2020$17,857,000
-36.1%
3,068,194
-1.6%
0.50%
-25.1%
Q4 2019$27,956,000
+4.3%
3,116,594
+0.4%
0.67%
-25.4%
Q3 2019$26,807,000
-25.2%
3,104,494
-3.5%
0.90%
-11.5%
Q2 2019$35,826,000
+14.4%
3,215,994
+36.6%
1.01%
+10.7%
Q1 2019$31,305,000
-10.7%
2,353,735
+3.7%
0.92%
-35.0%
Q4 2018$35,058,000
+9.8%
2,269,136
+1.2%
1.41%
+43.6%
Q3 2018$31,935,0002,242,6360.98%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 4,450,638$17,536,0001.82%
EcoR1 Capital, LLC 3,421,287$13,480,0000.72%
FRAZIER MANAGEMENT LLC 2,061,758$8,123,0000.63%
BVF INC/IL 2,695,418$10,620,0000.42%
Column Group LLC 869,493$3,426,0000.31%
Avidity Partners Management LP 2,122,064$8,361,0000.27%
Redmile Group, LLC 3,059,794$12,056,0000.15%
SkyOak Wealth, LLC 69,778$275,0000.09%
Tekla Capital Management LLC 419,005$1,651,0000.06%
Blackstone Inc. 2,567,445$10,116,0000.04%
View complete list of GRITSTONE ONCOLOGY INC shareholders